Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

Ashish C. Bhatia MD, FAAD Associate Editor

Eliot N. Mostow MD, MPH Associate Editor

Sarah L. Chamlin MD Advisory Board

See All Experts

featured

Published in Dermatology

Journal Scan / Research · February 02, 2023

Safety and Efficacy of Dupilumab in Adults With Atopic Dermatitis

Journal of the European Academy of Dermatology and Venereology: JEADV

Save Recommend

Sign in to PracticeUpdate

Only registered members have full access to PracticeUpdate content.

Not a member?

Join for free

Disclosure statements are available on the authors' profiles:

Robert Sidbury MD, MPH

Journal of the European Academy of Dermatology and Venereology: JEADV

A nationwide 104 weeks real-world study of dupilumab in adults with atopic dermatitis: Ineffectiveness in head-and-neck dermatitis

J Eur Acad Dermatol Venereol 2023 Jan 06;[EPub Ahead of Print], I Vittrup, NS Krogh, HHP Larsen, J Elberling, L Skov, KS Ibler, GBE Jemec, CG Mortz, RO Bach, C Bindslev-Jensen, MG Dalager, A Egeberg, T Agner, M Deleuran, C Vestergaard, JP Thyssen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Safety and Efficacy of Dupilumab in Adults With Atopic Dermatitis

Additional Info

A nationwide 104 weeks real-world study of dupilumab in adults with atopic dermatitis: Ineffectiveness in head-and-neck dermatitis

Further Reading

Rebound Growth of Infantile Hemangiomas After Discontinuation of Treatment With Propranolol vs Atenolol

Allergic Contact Cheilitis/Stomatitis Owing to Beverages and Food

Assessing Skin Cancer Diagnosis Accuracy by Lesion Type, Physician Experience, and Examination Method

Doxycycline Post-Exposure Prophylaxis for Bacterial Sexually Transmitted Infection Prevention

Association Between 5α-Reductase Inhibitor Use for Dermatologic Conditions and the Risk of Breast or Gynecologic Cancers

Efficacy of Treatment With Secukinumab in Patients With Hidradenitis Suppurativa

Local Recurrence, Metastasis, and Mortality Rates Among Patients With Thin and In Situ Melanomas

Suicidal and Self-Injurious Behaviors Among Patients With Psoriasis or Psoriatic Arthritis Treated With Biologics

Efficacy and Safety of Combined Topical 17α-Ethinyl Estradiol With Minoxidil vs Topical Minoxidil Alone in Patients With Female Pattern Hair Loss

Clinical Features and Treatment Outcomes Among Patients With Primary Cutaneous B-Cell Lymphomas

Clinical Characteristics and Outcomes of DPP-4 Inhibitor–Associated Bullous Pemphigoid

Recently Updated